RE:Look at itYou posted the exact same yesterday and even highlighted it all lol. So I'll say again, the patent is 2030 and FSD won't be done testing till 2021 at earliest. That leaves less than 9 years on patent. Secondly who cares what the investors could do. It's 10.1 million until they do more. Not 20 or any other made up number. 10.1. Yes they sold cannara for 7.7 mill and at end of March 31 has 8 million total in bank. Going by their financials they should have around 14-15 million right now. That's it. They don't have 20 million and they haven't sold the building but they are paying for it, and it's not cheap. They have enough money to get them into 2021 after that we shall see. Those are facts not highlighted guesses and hopes. Nice on the new accounts though. Can hardly tell it's the same person.
EGEGELGELGEL123 wrote: 10 Million Dollar raise created some dilution but they need it to advance their efforts pharma business isn’t free and is costly things take time and most importantly money. We have been given a life force with that 10 million, keep in mind those institutional investors have an option of investing an additional $10,000,000 on top of the first private placement. So that is like almost 20,000,000, the FSD pharma facility isn’t sold yet and that would have been another 19 million. They sold cannara for 8 million. Hopefully that is enough to pay for phase 1 in Australia the new have phase 2 costs.